
SOHO invests in next generation of hematologic oncologists
Each year, SOHO awards travel scholarships to budding early-career physicians and researchers to attend the SOHO Annual Meeting in Houston, Texas, to present their research.
The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Each year, SOHO awards travel scholarships to budding early-career physicians and researchers to attend the SOHO Annual Meeting in Houston, Texas, to present their research.

Rami Komrokji, MD, of the Moffitt Cancer Center in Tampa, Florida, and colleagues will present the findings at the 2026 SOHO Annual Meeting.

The study, led by Raúl Azibeiro Melchor, of Hospital Universitario de Salamanca in Spain, will be presented at the Fourteenth Annual Meeting of the Society of Hematologic Oncology in Houston, Texas.

Patients with telomere biology disorders (TBDs) exhibited substantial hematologic and multiorgan morbidity as well as frequent clonal hematopoiesis with a high rate of PPM1D and U2AF1 mutations, according to a single-center retrospective cohort study led by Olisaemeka Ogbue, MBBS, of Mayo Clinic in Rochester, Minnesota.

The analysis, led by Elias Jabbour, MD, of University of Texas MD Anderson Cancer Center in Houston, was presented at the Fourteenth Annual Meeting of the Society of Hematologic Oncology in Houston, Texas.

The discussion focuses on whether patients in complete molecular remission still need an allogeneic stem cell transplant, alongside methods to prevent T-cell fratricide using CRISPR and base editing. Dr. DiPersio also covers cross-specialty efforts led by pediatric groups like Charles Mulligan and St. Jude’s to decode transcriptional subsets, pointing to international trials across the United States, Europe, and China evaluating off-the-shelf allogeneic products and targeted interventions.
SOHO Insider is the official media platform of the Society of Hematologic Oncology. The SOHO Insider Editorial Board is comprised of leading hematologists. Learn more about our editorial board and SOHO Insider platforms.
Submit your difficult clinical questions to the Ask-the-Expert forum in the SOHO mobile app. Submit your questions in our exclusive members-only forums community on the SOHO mobile app. Your inquiry will be sent directly to leading experts, including Dr. Hagop Kantarjian, Dr. Kami Maddocks, Dr. Sagar Lonial, and Dr. Mascarenhas for their insights.
Follow the instructions below to ask a question now!
Benefits of membership include:
The Career Center provides SOHO members with the ability to find jobs in the field of Hematologic Oncology along with a variety of career advice. Select the 'Career Center' button to explore new job opportunities and career information.
The Career Center Allows SOHO Members to:
To access the SOHO Career Center click the following link.